Literature DB >> 21200396

Prevention: will an aspirin a day keep the colorectal cancer away?

Marianne Berg1, Kjetil Søreide.   

Abstract

Entities:  

Year:  2011        PMID： 21200396     DOI： 10.1038/nrclinonc.2010.225

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Aspirin to prevent colorectal cancer: time to act?

Authors:  Robert Benamouzig; Bernard Uzzan
Journal:  Lancet       Date:  2010-10-21       Impact factor: 79.321

2.  Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

Authors:  Peter M Rothwell; Michelle Wilson; Carl-Eric Elwin; Bo Norrving; Ale Algra; Charles P Warlow; Tom W Meade
Journal:  Lancet       Date:  2010-10-21       Impact factor: 79.321

Review 3.  A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.

Authors:  J T Cross; E M Poole; C M Ulrich
Journal:  Pharmacogenomics J       Date:  2008-01-15       Impact factor: 3.550

4.  Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.

Authors:  Robert Benamouzig; Bernard Uzzan; Antoine Martin; Jacques Deyra; Julian Little; Bernard Girard; Stanislas Chaussade
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

5.  Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.

Authors:  Rachel S Midgley; Christopher C McConkey; Elaine C Johnstone; Janet A Dunn; Justine L Smith; Simon A Grumett; Patrick Julier; Claire Iveson; Yoko Yanagisawa; Bryan Warren; Michael J Langman; David J Kerr
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

Review 6.  Molecular origins of cancer: Molecular basis of colorectal cancer.

Authors:  Sanford D Markowitz; Monica M Bertagnolli
Journal:  N Engl J Med       Date:  2009-12-17       Impact factor: 91.245

Review 7.  The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials.

Authors:  F Gao; C Liao; L Liu; A Tan; Y Cao; Z Mo
Journal:  Colorectal Dis       Date:  2009-11-14       Impact factor: 3.788

8.  Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study.

Authors:  Helene Kirkegaard; Nina Føns Johnsen; Jane Christensen; Kirsten Frederiksen; Kim Overvad; Anne Tjønneland
Journal:  BMJ       Date:  2010-10-26

9.  15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.

Authors:  Min Yan; Seung-Jae Myung; Stephen P Fink; Earl Lawrence; James Lutterbaugh; Peiying Yang; Xiaohua Zhou; Danielle Liu; Ronald M Rerko; Joseph Willis; Dawn Dawson; Hsin-Hsiung Tai; Jill S Barnholtz-Sloan; Robert A Newman; Monica M Bertagnolli; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

10.  Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

Authors:  Andrew T Chan; Shuji Ogino; Charles S Fuchs
Journal:  N Engl J Med       Date:  2007-05-24       Impact factor: 91.245
  10 in total
  2 in total

1.  Characterization of an arachidonic acid-deficient (Fads1 knockout) mouse model.

Authors:  Yang-Yi Fan; Jennifer M Monk; Tim Y Hou; Evelyn Callway; Logan Vincent; Brad Weeks; Peiying Yang; Robert S Chapkin
Journal:  J Lipid Res       Date:  2012-04-25       Impact factor: 5.922

Review 2.  Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.

Authors:  Robert M Starke; Nohra Chalouhi; Dale Ding; David M Hasan
Journal:  Cerebrovasc Dis       Date:  2015-05-07       Impact factor: 2.762
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.